Article Data

  • Views 1595
  • Dowloads 217

Case Report

Open Access

Prostate leiomyosarcoma treatment using three-dimensional reconstruction: a case report and literature review

  • Zhu-Nan Xu1,†
  • Tong Cai1,†
  • Zhong-Bao Zhou2
  • Ji-Tao Wu3
  • Zhen-Li Gao4

1Binzhou Medical University, Yantai, 264003 Shandong, P. R. China and Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000 Shandong, P. R. China

2Department of Urology, Beijing TianTan Hospital, Capital Medical University. No.119 South 4th Ring West Road, Fengtai District, 100070 Beijing, P. R. China

3Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000 Shandong, P. R. China

4Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000 Shandong, P. R. China and Binzhou Medical University, Yantai, 264003 Shandong, P. R. China

DOI: 10.31083/jomh.2021.018 Vol.17,Issue 2,April 2021 pp.148-153

Published: 08 April 2021

*Corresponding Author(s): Zhen-Li Gao E-mail: xzn13791280550@163.com

† These authors contributed equally.

Abstract

Background: Prostate sarcoma is a malignant tumor from the prostate stroma. However, its pathogenesis is unknown. This is a rare type of prostate tumor.

Case Presentation: A rare case of prostate leiomyosarcoma has been described. A 55-year-old prostate leiomyosarcoma patient who suffered from progressive dysuria and frequent urination for half a year was examined. Pathology, immunohistochemical staining, and laparoscopic radical prostatectomy were performed using three-dimensional (3D) reconstruction to diagnose prostate leiomyosarcoma. The patient did not receive adjuvant therapy after the operation. Final pathology was used to confirm prostate leiomyosarcoma. After one year of follow-up, the patient regularly underwent a digital rectal examination and abdominal MRI. However, no tumor recurrence or metastasis was found.

Discussion: We discussed diagnosis and treatment of prostate leiomyosarcoma and reviewd literatures.

Conclusion: Prostate leiomyosarcoma is a rare special type of prostate tumor, and its diagnosis is mainly based on pathological features. Radical excision is the primary treatment for prostate leiomyosarcoma. The 3D reconstruction is essential in the surgery because it can determine the size of the tumor and its relationship to the surrounding tissue. A postoperative adjuvant therapy can also be performed.

Keywords

Prostate leiomyosarcoma; diagnosis; treatment; three-dimensional reconstruction; case report

Cite and Share

Zhu-Nan Xu,Tong Cai,Zhong-Bao Zhou,Ji-Tao Wu,Zhen-Li Gao. Prostate leiomyosarcoma treatment using three-dimensional reconstruction: a case report and literature review. Journal of Men's Health. 2021. 17(2);148-153.

References

[1] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013; 63: 11-30.

[2] Rojas-Jiménez A, Otero-Garcia M, Mateos-Martin A. Stromal pro-static sarcoma: a rare tumor with rare clinical and imaging presen-tation. Journal of Radiology Case Reports. 2013; 7: 24-31.

[3] Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. Journal of Clinical Epidemiology. 2017; 89: 218- 235.

[4] Schubert C, van Langeveld MC, Donoso LA. Innovations in 3D printing: a 3D overview from optics to organs. British Journal of Ophthalmology. 2014; 98: 159-161.

[5] Bird J. Exploring the 3D printing opportunity. The Financial Times. 2012.

[6] George A. 3-D printed car is as strong as steel, half the weight, and nearing production. Wired. 2013. Available at: http: //www.wired.com/autopia/2013/02/3d-printed-car/

(Accessed: 27 February 2015).

[7] Marks P. 3D printing: the world’s first printed plane. New Scientist. 2011. Available at: http://www.newscientist.com/article/dn20737-3d-printing-the-worlds-first-printed-plane.html#Ux4SLx_LI7x (Accessed: 01 August 2014).

[8] Greenberg A. Meet the ‘liberator’: test-firing the world’s first fully 3D-printed gun. Forbes. 2013. Available at: http://www.forbes.com/sites/andygreenberg/2013/05/05/meet-the-liberator-test-firing-the-worlds-first-fully-3d-printed-gun/(Accessed: 14 June 2015).

[9] Macguire E. Dutch architects build world’s first 3D printed house. CNN. 2015. Available at: http://edition.cnn.com/2014/04/ 13/business/3d-printed-house-amsterdam/ (Accessed: 14 April 2015).

[10] Mondaini N, Palli D, Saieva C, Nesi G, Franchi A, Ponchietti R, et al. Clinical characteristics and overall survival in genitourinary sarcomas treated with curative intent: a multicenter study. European Urology. 2005; 47: 468-473.

[11] Humphrey PA. Angiosarcoma of the prostate. The Journal of Urology. 2012; 187: 684-685.

[12] Ren FY, Lu JP, Wang J, Ye JJ, Shao CW, Wang MJ. Adult prostate sarcoma: radiological-clinical correlation. Clinical Radiology. 2009; 64: 171-177.

[13] Boyle H, Fléchon A, Droz JP. Treatment of uncommon malignant tumours of the bladder. Current Opinion in Urology. 2011; 21: 309-314.

[14] Zazzara M, Divenuto L, Scarcia M, Cardo G, Maselli FP, Ludovico GM. Leiomyosarcoma of prostate: case report and literature review. Urology Case Reports. 2017; 17: 4-6.

[15] Vandoros GP, Manolidis T, Karamouzis MV, Gkermpesi M, Lam-bropoulou M, Papatsoris AG, et al. Leiomyosarcoma of the prostate: case report and review of 54 previously published cases. Sarcoma. 2008; 2008: 458709.

[16] Kaufman JJ, Berneike RR. Leiomyoma of the prostate. The Journal of Urology. 1951; 65: 297-310.

[17] Dotan ZA, Tal R, Golijanin D, Snyder ME, Antonescu C, Brennan MF, et al. Adult genitourinary sarcoma: the 25-year memorial Sloan-Kettering experience. Journal of Urology. 2006; 176: 2033-2039.

[18] Janet NL, May A, Akins RS. Sarcoma of the prostate: a single institutional review. American Journal of Clinical Oncology. 2009; 32: 27-29.

[19] Miedler JD, Maclennan GT. Leiomyosarcoma of the prostate. The Journal of Urology. 2007; 178: 668.

[20] Hossain D, Meiers I, Qian J, MacLennan GT, Bostwick DG. Prostatic leiomyoma with atypia: follow-up study of 10 cases. Annals of Diagnostic Pathology. 2008; 12: 328-332.

[21] Sexton WJ, Lance RE, Reyes AO, Pisters PWT, Tu S, Pisters LL. Adult prostate sarcoma: the M. D. Anderson Cancer Center experience. Journal of Urology. 2001; 166: 521-525.

[22] Cheville JC, Dundore PA, Nascimento AG, Meneses M, Kleer E, Farrow GM, et al. Leiomyosarcoma of the prostate. Report of 23 cases. Cancer. 1995; 76: 1422-1427.

[23] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology. 2010; 17: 1471-1474.

[24] Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. The New England Journal of Medicine. 2005; 353: 701-711.

[25] Lin M, Hsiao H. Promising effects of pazopanib with radiation on an advanced prostate leiomyosarcoma after failure of systemic chemotherapy. The Kaohsiung Journal of Medical Sciences. 2019; 35: 317- 318.

[26] Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. Journal of Clinical Oncology. 2003; 21: 4342-4349.

[27] Porpiglia F, Bertolo R, Checcucci E, Amparore D, Autorino R, Das-gupta P, et al. Development and validation of 3D printed virtual models for robot-assisted radical prostatectomy and partial nephrectomy: urologists’ and patients’ perception. World Journal of Urology. 2018; 36: 201-207.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.7 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top